Targeted Strategies for Today's Evolving Markets

MissionIR Blog

CytoSorbents (CTSO) Presents at Rodman & Renshaw Conference

CytoSorbents Corp. (NASDAQ: CTSO) is a critical care immunotherapy company using blood purification to treat life-threatening illnesses. The company has developed a new hemoperfusion technology for removing toxins from the blood associated with sepsis, kidney disease, and other conditions. With its flagship product, CytoSorb, approved in the European Union and marketed in 29 countries worldwide, CytoSorbents is committed to helping save the lives and improve the outcomes of critically-ill patients and patient undergoing cardiac surgery around the world. For more information, visit the company’s website at

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Comments are closed.